.svg){kind=icon}
Brand and Portfolio Strategy
Be proactive about growing your brand using the latest in data, analytics, and domain expertise.
Maximize launch precision, speed and impact
On average, post-pandemic launch trajectories underperform and are declining. Resilient launches generally combine a strong clinical story, reduced healthcare burden, and high levels of engagements.
IQVIA is an end-to-end strategic partner for launch planning, execution and monitoring. Maximize your success rate by ensuring consistency of best practices and leverage community-based knowledge sharing to achieve launch excellence for your brand.
Launch excellence has never been more challenging
First six months are critical for launch
The “six month” window still applies meaning most launches have only one shot at success.
80% of launches continue as they start in the first six months.
Most companies even well resourced and experienced struggle to deliver excellence across launches and consistent launch excellence are even harder to achieve the more frequently you launch.
Achieve launch excellence
With over three decades of experience and a deep analysis of over 1000 innovative launches, IQVIA knows what it takes to achieve launch excellence.
IQVIA offers end-to-end strategic support throughout launch planning, execution and monitoring.
Global launch excellence is a comprehensive and cohesive way to fully optimize on all launch opportunities.
Take a proven approach to launch excellence
Research on post-pandemic launch excellence identified three key environmental challenges that require a new approach: patient access, HCP access and market access.
To succeed, companies must change how they prepare for launch with renewed focus on three key areas:
- Healthcare system readiness
- Content driven interactive engagement
- Evidence requirements
IQVIA offers a connected approach structured around five foundational success factors to achieve launch excellence.
White Paper
Placing The Right Bets - Defining Tailored Investment Strategies for Pharma Launch
This IQVIA white paper outlines a tailored, archetype‑driven approach to pharma launch investment, helping companies optimise OPEX across diverse therapeutic landscapes. It explains four launch archetypes—Share of Voice, Science‑led, Ecosystem Building and CoE‑focused—and how they guide decisions on when, where and how much to invest. With real‑world case studies and benchmarks, the paper shows how smarter, evidence‑based spending can improve launch performance, shape emerging therapy areas, and strengthen portfolio planning in increasingly complex, competitive markets.
Launch Excellence Podcast Series
Visit IQVIA’s Launch Excellence Podcast Series to learn more about the top issues and latest trends that are shaping the future of successful commercial launches. Gain insightful perspectives from industry experts in order to drive innovative and agile launches in a more complex patient journey.
Listen to our most recent episode below or click on view podcasts link to access all available episodes.
Industry Article
Beyond Weight Loss: The Future of Obesity Treatment
Obesity treatment is evolving beyond weight loss, with GLP-1 receptor agonists leading a new era of multi-indication therapies targeting cardiometabolic, CNS, and other chronic conditions. This transformation signals a future of precision medicine, combination strategies, and real-world evidence driving innovation.
Industry Article
Think Tank – Key Elements of Successful Launches
In this article by PM360, IQVIA expert Vineet Purwar discusses the role that innovation—whether in digital engagement, real-world evidence or patient support—plays in maximizing launch impact.
Related solutions
Pricing and Market Access
Understand how payers, providers, and patients define value, and accelerate market access for new and innovative products.
Omnichannel Engagement and Insights
Maximize the value of your brand with personalized, precise, and efficient communications.